763 related articles for article (PubMed ID: 19638591)
1. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
Kraus S; Levy G; Hanoch T; Naor Z; Seger R
Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
[TBL] [Abstract][Full Text] [Related]
5. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
Eicke N; Günthert AR; Emons G; Gründker C
Int J Oncol; 2006 Nov; 29(5):1223-9. PubMed ID: 17016655
[TBL] [Abstract][Full Text] [Related]
6. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
8. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu YL; Kuo PL; Lin LT; Lin CC
J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
[TBL] [Abstract][Full Text] [Related]
9. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
[TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells.
Reno EM; Haughian JM; Jackson TA; Thorne AM; Bradford AP
Apoptosis; 2009 Jun; 14(6):809-20. PubMed ID: 19424800
[TBL] [Abstract][Full Text] [Related]
12. Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3.
Lu T; Huang CC; Lu YC; Lin KL; Liu SI; Wang BW; Chang PM; Chen IS; Chen SS; Tsai JY; Chou CT; Jan CR
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):297-303. PubMed ID: 18986328
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
[TBL] [Abstract][Full Text] [Related]
14. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
15. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
16. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
Joo SS; Yoo YM
J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
[TBL] [Abstract][Full Text] [Related]
17. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
Binet F; Girard D
J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151
[TBL] [Abstract][Full Text] [Related]
18. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
[TBL] [Abstract][Full Text] [Related]
19. Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells.
Rabi T; Banerjee S
Mol Carcinog; 2008 Jun; 47(6):415-23. PubMed ID: 18058803
[TBL] [Abstract][Full Text] [Related]
20. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]